1. 014 Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach. (25th April 2018) Authors: Nisar, Muhammad K Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 015 Giant cell hepatitis with CTD and ILD: mycophenolate mofetil treating an elusive multi system disease. (25th April 2018) Authors: Nisar, Muhammad K Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 071 Do dedicated early arthritis clinics improve patient outcomes? A real world study. (25th April 2018) Authors: Niazi, Ghulam A; Nisar, Muhammad K Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 071 Does biologic retention vary with methotrexate co-prescription dose in established RA? A real world study. (12th April 2019) Authors: Mothojakan, Nadira B; Nisar, Muhammad K Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 122 Secukinumab and solid organ cancer: are they mutually exclusive?. (12th April 2019) Authors: Nisar, Muhammad K Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 147 Do dedicated early arthritis clinics improve psoriatic arthritis outcomes? A real world study. (12th April 2019) Authors: Nisar, Muhammad K Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 180 Does the quality & outcomes framework (QOF) indicator for osteoporosis work? A primary care study. (12th April 2019) Authors: Parvin, Sultana; Barhey, Manraj; Nisar, Muhammad K Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 204 Switching to biosimilar rituximab: a real world study. (12th April 2019) Authors: Nisar, Muhammad K Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 267 Can community pharmacy services help early identification of psoriatic arthritis? A novel proof of concept study. (25th April 2018) Authors: Mehra, Pankaj; Baqai, Tanya; Nisar, Muhammad K Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 274 Rheumatology nurse specialists and corticosteroid prescribing: is it safe?. (25th April 2018) Authors: Begum, Julie; Nisar, Muhammad K Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗